All Stories

  1. Tumor-shrinking effects of enfortumab vedotin between primary urothelial carcinoma and metastatic organs

    Article • Frontiers in Oncology, January 2025, Frontiers

    Dr Shigekatsu Maekawa

  2. Changes in Renal Function After Nephroureterectomy for Upper Tract Urothelial Cancer in Elderly Patients

    Article • Cureus, June 2024, Springer Science + Business Media

    Dr Shigekatsu Maekawa

  3. Successful treatment of eosinophilia associated with dialysis‐related renal cancer with radical nephrectomy

    Article • IJU Case Reports, April 2024, Wiley

    Dr Shigekatsu Maekawa

  4. Abstract 7629: Association between COMT expression and therapeutic efficacy of androgen receptor-axis targeted in prostate cancer

    Article • Cancer Research, March 2024, American Association for Cancer Research (AACR)

    Dr Shigekatsu Maekawa

  5. Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review

    Article • Cancers, January 2024, MDPI AG

    Dr Shigekatsu Maekawa

  6. Metastatic bladder cancer forming a sigmoidorectal fistula after enfortumab vedotin therapy: a case report

    Article • Frontiers in Oncology, November 2023, Frontiers

    Dr Shigekatsu Maekawa

  7. Two cases of pelvic hematoma after prostatic urethral lift surgery

    Article • IJU Case Reports, October 2023, Wiley

    Dr Shigekatsu Maekawa

  8. Abstract 1416: Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis

    Article • Cancer Research, April 2023, American Association for Cancer Research (AACR)

    Dr Shigekatsu Maekawa

  9. Site-specific patterns of early response to nivolumab plus ipilimumab therapy in advanced renal cell carcinoma patients compared with tyrosine-kinase inhibitors

    Article • International Immunopharmacology, December 2022, Elsevier

    Dr Shigekatsu Maekawa

  10. P35-8 BRCA mutation test for castration-resistant prostate cancer in Iwate prefecture, Japan

    Article • Annals of Oncology, July 2022, Elsevier

    Dr Shigekatsu Maekawa

  11. A case of male perineal aggressive angiomyxoma with expressions of female hormone receptors

    Article • IJU Case Reports, May 2022, Wiley

    Dr Shigekatsu Maekawa

  12. PD55-04 EFFECT OF NEOADJUVANT CHEMOTHERAPY ON THE IMMUNE MICROENVIRONMENT IN MUSCLE INVASIVE BLADDER CANCER

    Article • The Journal of Urology, September 2021, Wolters Kluwer Health

    Dr Shigekatsu Maekawa

  13. TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer

    Article • Translational Oncology, January 2021, Elsevier

    Dr Shigekatsu Maekawa

  14. Recurrent massive myxoid liposarcoma in retroperitoneum 10 years post initial operation

    Article • IJU Case Reports, August 2019, Wiley

    Dr Shigekatsu Maekawa

  15. Influence of lifestyle choices on risks of CYP1B1 polymorphisms for prostate cancer

    Article • Journal of Cellular and Molecular Medicine, August 2018, Wiley

    Dr Shigekatsu Maekawa

  16. Clinical significance of random bladder biopsy in primary T1 bladder cancer

    Article • Molecular and Clinical Oncology, March 2018, Spandidos Publications

    Dr Shigekatsu Maekawa

  17. chromophobe renal cell carcinoma

    Article • International Journal of Urology, September 2015, Wiley

    Dr Shigekatsu Maekawa

  18. PD3-05 RECURRENT SOMATIC MUTATIONS UNDERLIE CORTICOTROPIN-INDEPENDENT CUSHING'S SYNDROME

    Article • The Journal of Urology, April 2015, Elsevier

    Dr Shigekatsu Maekawa

  19. 714 Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome

    Article • European Urology Supplements, April 2015, Elsevier

    Dr Shigekatsu Maekawa

  20. TMPRSS2 Met160Val polymorphism: Significant association with sporadic prostate cancer, but not with latent prostate cancer in Japanese men

    Article • International Journal of Urology, July 2014, Wiley

    Dr Shigekatsu Maekawa

  21. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome

    Article • Science, May 2014, American Association for the Advancement of Science

    Dr Shigekatsu Maekawa

  22. MP28-19 GENOME-WIDE ANALYSIS OF COPY NUMBER ALTERATIONS IN RENAL-PELVIC AND URETERAL CANCERS

    Article • The Journal of Urology, April 2014, Elsevier

    Dr Shigekatsu Maekawa

  23. Integrated molecular analysis of clear-cell renal cell carcinoma

    Article • Nature Genetics, June 2013, Nature

    Dr Shigekatsu Maekawa

  24. Abstract 3184: Integrative analysis of clear cell renal cell carcinoma.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr Shigekatsu Maekawa

  25. 634 GENOME-WIDE ANALYSIS OF COPY NUMBER ALTERATIONS IN RENAL-PELVIC AND URETERAL CANCERS

    Article • The Journal of Urology, April 2012, Elsevier

    Dr Shigekatsu Maekawa